Abstract:Drug repositioning is a strategy of repurposing approved drugs for treating new indications, which can accelerate the drug discovery process, reduce development costs, and lower the safety risk. The advancement of biotechnology has significantly accelerated the speed and scale of biological data generation, offering significant potential for drug repositioning through biomedical knowledge graphs that integrate diverse entities and relations from various biomedical sources. To fully learn the semantic information and topological structure information from the biological knowledge graph, we propose a knowledge graph convolutional network with a heuristic search, named KGCNH, which can effectively utilize the diversity of entities and relationships in biological knowledge graphs, as well as topological structure information, to predict the associations between drugs and diseases. Specifically, we design a relation-aware attention mechanism to compute the attention scores for each neighboring entity of a given entity under different relations. To address the challenge of randomness of the initial attention scores potentially impacting model performance and to expand the search scope of the model, we designed a heuristic search module based on Gumbel-Softmax, which uses attention scores as heuristic information and introduces randomness to assist the model in exploring more optimal embeddings of drugs and diseases. Following this module, we derive the relation weights, obtain the embeddings of drugs and diseases through neighborhood aggregation, and then predict drug-disease associations. Additionally, we employ feature-based augmented views to enhance model robustness and mitigate overfitting issues. We have implemented our method and conducted experiments on two data sets. The results demonstrate that KGCNH outperforms competing methods. In particular, case studies on lithium and quetiapine confirm that KGCNH can retrieve more actual drug-disease associations in the top prediction results.

Knowledge-driven drug repurposing using a comprehensive drug knowledge graph

Knowledge Graphs for drug repurposing: a review of databases and methods

KG-Predict: A knowledge graph computational framework for drug repurposing

EKGDR: An End-to-End Knowledge Graph-Based Method for Computational Drug Repurposing

Toward Better Drug Discovery with Knowledge Graph

A Multimodal Framework for Improving in Silico Drug Repositioning with the Prior Knowledge from Knowledge Graphs

Drug Repurposing using Consilience of Knowledge Graph Completion Methods

Explainable drug repurposing via path based knowledge graph completion

A knowledge graph approach to drug repurposing for Alzheimer's, Parkinson's and Glioma using drug-disease-gene associations

SynDRep: A Knowledge Graph-Enhanced Tool based on Synergistic Partner Prediction for Drug Repurposing

KGML-xDTD: a knowledge graph–based machine learning framework for drug treatment prediction and mechanism description

DrugRep-HeSiaGraph: when heterogenous siamese neural network meets knowledge graphs for drug repurposing

Knowledge Graph Convolutional Network with Heuristic Search for Drug Repositioning

Generating Drug Repurposing Hypotheses through the Combination of Disease-Specific Hypergraphs

DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features

Biomedical knowledge graph learning for drug repurposing by extending guilt-by-association to multiple layers

RareDR: A Drug Repositioning Approach for Rare Diseases Based on Knowledge Graph.

Learning a Patent-Informed Biomedical Knowledge Graph Reveals Technological Potential of Drug Repositioning Candidates

KGML-xDTD: A Knowledge Graph-based Machine Learning Framework for Drug Treatment Prediction and Mechanism Description

Drug prioritization using the semantic properties of a knowledge graph

Analysis of Drug repurposing Knowledge graphs for Covid-19